The Government Analyst Food and Drug Department is advising breast cancer patients who use Avastin to contact their physicians since the United States Food and Drug Administration (FDA) has found no evidence that the drug can delay tumour growth or prolong life.
In a press release, the Analyst Department said the FDA announced that after reviewing available studies, it
